D. H. Lee

Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial

Luis Paz‐Ares, E.H. Tan, Kenneth J. O’Byrne et al. · Annals of Oncology · 2017 · 522 citations · Full text

Medicine, Oncology, Pharmacology +16

The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery

Young Ho Yun, Y.A. Kim, Ye Min et al. · Annals of Oncology · 2012 · 195 citations

Medicine, Oncology, Surgery +16

Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial

Martin Schüler, Rossana Berardi, Wan‐Teck Lim et al. · Annals of Oncology · 2020 · 98 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II study of erlotinib as a salvage treatment for non-small-cell lung cancer patients after failure of gefitinib treatment

D. H. Lee, S.-W. Kim, Chong Hyun Suh et al. · Annals of Oncology · 2008 · 78 citations · Full text

Medicine, Oncology, Pharmacology +12

Mechanism of multiple infarcts in multiple cerebral circulations on diffusion-weighted imaging

A Hyun Cho, Jung Soo Kim, Sang-Ryong Jeon et al. · Journal of Neurology · 2007 · 39 citations

Medicine, Neurology, Neuroscience +14